Evolocumab News
Evolocumab currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Evolocumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Hypercholesterolaemia and mixed dyslipidaemia Repatha is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:...
- Evidence level: L5
- Predicted indications (20):
- symptomatic form of hemophilia in female carriers (99.8%)
- familial apolipoprotein C-II deficiency (99.5%)
- thrombocytopenic purpura (99.4%)
- factor XI deficiency (99.3%)
- hemophilia A with vascular abnormality (99.2%)
- disease of catalytic activity (99.1%)
- hemorrhagic disease of newborn (98.9%)
- ichthyosis, X-linked, without steroid sulfatase deficiency (98.8%)
- inherited thrombophilia (98.8%)
- disorder of other vitamins and cofactors metabolism and transport (98.8%)
- adenosine deaminase deficiency (98.8%)
- xanthomatosis (disease) (98.8%)
- esophageal varices without bleeding (98.8%)
- esophageal varices with bleeding (98.8%)
- 46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect (98.7%)
- 3-hydroxyacyl-CoA dehydrogenase deficiency (98.7%)
- cholesterol catabolic process disease (98.7%)
- coagulation protein disease (98.7%)
- 46,XY disorder of sex development due to a cholesterol synthesis defect (98.6%)
- neutral lipid storage disease (98.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.